Sessions
December 1, 2021
The treatment of multiple sclerosis (MS) has been transformed by the successful development of immunotherapies that efficiently reduce...
Poster-Disease-modifying Therapy
October 25, 2021
Background: Limited data on baseline (BL) characteristics and disease severity exist for Black/African American (AA) patients with multiple...
